These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 19632946

  • 1. The rationale and development of therapeutic insulin-like growth factor axis inhibition for lung and other cancers.
    Camidge DR, Dziadziuszko R, Hirsch FR.
    Clin Lung Cancer; 2009 Jul; 10(4):262-72. PubMed ID: 19632946
    [Abstract] [Full Text] [Related]

  • 2. The insulin-like growth factor pathway in lung cancer.
    Dziadziuszko R, Camidge DR, Hirsch FR.
    J Thorac Oncol; 2008 Aug; 3(8):815-8. PubMed ID: 18670298
    [Abstract] [Full Text] [Related]

  • 3. Biological & physiological aspects of action of insulin-like growth factor peptide family.
    Pavelić J, Matijević T, Knezević J.
    Indian J Med Res; 2007 Apr; 125(4):511-22. PubMed ID: 17598937
    [Abstract] [Full Text] [Related]

  • 4. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
    Reeve JG, Morgan J, Schwander J, Bleehen NM.
    Cancer Res; 1993 Oct 01; 53(19):4680-5. PubMed ID: 7691401
    [Abstract] [Full Text] [Related]

  • 5. Alteration of the insulin-like growth factor axis during in vitro differentiation of the human osteosarcoma cell line HOS 58.
    Viereck V, Siggelkow H, Pannem R, Braulke T, Scharf JG, Kübler B.
    J Cell Biochem; 2007 Sep 01; 102(1):28-40. PubMed ID: 17372931
    [Abstract] [Full Text] [Related]

  • 6. Gastric cancer: the role of insulin-like growth factor 2 (IGF 2) and its receptors (IGF 1R and M6-P/IGF 2R).
    Pavelić K, Kolak T, Kapitanović S, Radosević S, Spaventi S, Kruslin B, Pavelić J.
    J Pathol; 2003 Nov 01; 201(3):430-8. PubMed ID: 14595755
    [Abstract] [Full Text] [Related]

  • 7. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors.
    Denley A, Carroll JM, Brierley GV, Cosgrove L, Wallace J, Forbes B, Roberts CT.
    Mol Cell Biol; 2007 May 01; 27(10):3569-77. PubMed ID: 17325037
    [Abstract] [Full Text] [Related]

  • 8. Insulin-like growth factor (IGF) I down-regulates type 1 IGF receptor (IGF 1R) and reduces the IGF I response in A549 non-small-cell lung cancer and Saos-2/B-10 osteoblastic osteosarcoma cells.
    Bostedt KT, Schmid C, Ghirlanda-Keller C, Olie R, Winterhalter KH, Zapf J.
    Exp Cell Res; 2001 Dec 10; 271(2):368-77. PubMed ID: 11716549
    [Abstract] [Full Text] [Related]

  • 9. Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro.
    Nakanishi Y, Mulshine JL, Kasprzyk PG, Natale RB, Maneckjee R, Avis I, Treston AM, Gazdar AF, Minna JD, Cuttitta F.
    J Clin Invest; 1988 Jul 10; 82(1):354-9. PubMed ID: 2839551
    [Abstract] [Full Text] [Related]

  • 10. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
    Wang Z, Chakravarty G, Kim S, Yazici YD, Younes MN, Jasser SA, Santillan AA, Bucana CD, El-Naggar AK, Myers JN.
    Clin Cancer Res; 2006 Aug 01; 12(15):4755-65. PubMed ID: 16899627
    [Abstract] [Full Text] [Related]

  • 11. Cyclooxygenase-2 modulates the insulin-like growth factor axis in non-small-cell lung cancer.
    Põld M, Krysan K, Põld A, Dohadwala M, Heuze-Vourc'h N, Mao JT, Riedl KL, Sharma S, Dubinett SM.
    Cancer Res; 2004 Sep 15; 64(18):6549-55. PubMed ID: 15374967
    [Abstract] [Full Text] [Related]

  • 12. Insulin-like growth factor receptor expression is associated with aggressive phenotypes and has therapeutic activity in biliary tract cancers.
    Ohashi H, Adachi Y, Yamamoto H, Taniguchi H, Nosho K, Suzuki H, Arimura Y, Imai K, Carbone DP, Shinomura Y.
    Cancer Sci; 2012 Feb 15; 103(2):252-61. PubMed ID: 22044563
    [Abstract] [Full Text] [Related]

  • 13. Selective inhibition of SCLC growth by the A12 anti-IGF-1R monoclonal antibody correlates with inhibition of Akt.
    Yeh J, Litz J, Hauck P, Ludwig DL, Krystal GW.
    Lung Cancer; 2008 May 15; 60(2):166-74. PubMed ID: 18006183
    [Abstract] [Full Text] [Related]

  • 14. Antagonists of growth hormone-releasing hormone inhibit the proliferation of experimental non-small cell lung carcinoma.
    Szereday Z, Schally AV, Varga JL, Kanashiro CA, Hebert F, Armatis P, Groot K, Szepeshazi K, Halmos G, Busto R.
    Cancer Res; 2003 Nov 15; 63(22):7913-9. PubMed ID: 14633721
    [Abstract] [Full Text] [Related]

  • 15. Controlling insulin-like growth factor activity and the modulation of insulin-like growth factor binding protein and receptor binding.
    McCusker RH.
    J Dairy Sci; 1998 Jun 15; 81(6):1790-800. PubMed ID: 9684185
    [Abstract] [Full Text] [Related]

  • 16. A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.
    Burtrum D, Zhu Z, Lu D, Anderson DM, Prewett M, Pereira DS, Bassi R, Abdullah R, Hooper AT, Koo H, Jimenez X, Johnson D, Apblett R, Kussie P, Bohlen P, Witte L, Hicklin DJ, Ludwig DL.
    Cancer Res; 2003 Dec 15; 63(24):8912-21. PubMed ID: 14695208
    [Abstract] [Full Text] [Related]

  • 17. Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma.
    Avnet S, Sciacca L, Salerno M, Gancitano G, Cassarino MF, Longhi A, Zakikhani M, Carboni JM, Gottardis M, Giunti A, Pollak M, Vigneri R, Baldini N.
    Cancer Res; 2009 Mar 15; 69(6):2443-52. PubMed ID: 19258511
    [Abstract] [Full Text] [Related]

  • 18. Insulin-like growth factor 1 is a potent stimulator of cervical cancer cell invasiveness and proliferation that is modulated by alphavbeta3 integrin signaling.
    Shen MR, Hsu YM, Hsu KF, Chen YF, Tang MJ, Chou CY.
    Carcinogenesis; 2006 May 15; 27(5):962-71. PubMed ID: 16400188
    [Abstract] [Full Text] [Related]

  • 19. Molecular interactions of the IGF system.
    Denley A, Cosgrove LJ, Booker GW, Wallace JC, Forbes BE.
    Cytokine Growth Factor Rev; 2005 May 15; 16(4-5):421-39. PubMed ID: 15936977
    [Abstract] [Full Text] [Related]

  • 20. Co-expression of messenger ribonucleic acids encoding IGF-I, IGF-II, type I and II IGF receptors and IGF-binding proteins (IGFBP-1 to -6) during follicular development in the ovary of seasonally anoestrous ewes.
    Hastie PM, Onagbesan OM, Haresign W.
    Anim Reprod Sci; 2004 Aug 15; 84(1-2):93-105. PubMed ID: 15302390
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.